Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02873962
Title A Phase II Study Of Nivolumab/ Bevacizumab
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute

peritoneum cancer

ovary epithelial cancer

fallopian tube cancer


Bevacizumab + Nivolumab

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.